Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Newmont Corporation (NEM) vs Viatris Inc (VTRS) Price & Performance

Newmont CorporationTrade
Viatris IncTrade

Price performance (Past 24H)

Key statistics

Newmont Corporation vs Viatris Inc — how do they compare? Newmont Corporation trades at $92.41 (market cap $95.23B), while Viatris Inc trades at $17.58 (market cap $19.79B). The key difference: Newmont Corporation is far larger — about 4.8× Viatris Inc's market cap, and Viatris Inc pays the higher dividend (2.83%). Which is the better fit depends on your goals.

NEMVTRS
Market Cap
$95.23B$19.79B
Sector
Basic MaterialsHealth
52-Week High
$131.95$17.39
52-Week Low
$59.86$8.74
Enterprise Value
$91.98B$32.00B
Dividend Yield
1.17%2.83%

Returns comparison

Trailing returns across standard periods

About Newmont Corporation

Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.

Read more on NEM

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Read more on VTRS